(Q33342339)

English

A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

metastatic melanoma

1 reference

based on heuristic

inferred from title

Steven Rosenberg

16

object named as

Steven A Rosenberg

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

4

object named as

Patrick Hwu

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Francesco Marincola

8

object named as

Francesco M Marincola

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Suzanne L. Topalian

6

object named as

Suzanne L Topalian

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Mark E Dudley

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

John R Wunderlich

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

James C Yang

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Douglas J Schwartzentruber

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Richard M Sherry

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Susan F Leitman

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Claudia A Seipp

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Linda Rogers-Freezer

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kathleen E Morton

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Azam Nahvi

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sharon A Mavroukakis

14

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Donald E White

15

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 May 2002

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Journal of Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

243-251

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2413438

21 June 2018

Interleukin-7: master regulator of peripheral T-cell homeostasis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2413438

21 June 2018

Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2413438

21 June 2018

Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2413438

21 June 2018

Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2413438

21 June 2018

A listing of human tumor antigens recognized by T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2413438

21 June 2018

High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2413438

21 June 2018

Interleukin-2 and the development of immunotherapy for the treatment of patients with cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2413438

21 June 2018

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2413438

21 June 2018

Thymic aging and T-cell regeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2413438

21 June 2018

Graft-versus-host effect after allogeneic hematopoietic stem cell transplantation: GVHD and GVL.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2413438

21 June 2018

Isolation of tyrosinase-specific CD8+ and CD4+ T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2413438

21 June 2018

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2413438

21 June 2018

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2413438

21 June 2018

Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2413438

21 June 2018

Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin 2, and local tumor irradiation. Studies on the mechanism of action

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2413438

21 June 2018

The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2413438

21 June 2018

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2413438

21 June 2018

Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2413438

31 October 2018

Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2413438

31 October 2018

Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12000866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Syngeneic adoptive immunotherapy and chemoimmunotherapy of a Friend leukemia: requirement for T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/12000866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/12000866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Localization of 111indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response

1 reference

https://pubmed.ncbi.nlm.nih.gov/12000866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/12000866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression

1 reference

https://pubmed.ncbi.nlm.nih.gov/12000866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

https://pubmed.ncbi.nlm.nih.gov/12000866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression

1 reference

https://pubmed.ncbi.nlm.nih.gov/12000866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor immunization with a minimal peptide epitope (G9-209-2M) leads to a functionally heterogeneous CTL response

1 reference

https://pubmed.ncbi.nlm.nih.gov/12000866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased tolerance to interleukin-2 with repeated courses of therapy in patients with metastatic melanoma or renal cell cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12000866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12000866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-cell clones from melanoma patients immunized against an anchor-modified gp100 peptide display discordant effector phenotypes

1 reference

https://pubmed.ncbi.nlm.nih.gov/12000866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/00002371-200205000-00007

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33342339&oldid=1906283241"